Explore All Access
Check if your research matches the topics covered in In Vivo?
- Degree of match
- Common matching concepts
- Additional journal recommendations
In Vivo : Impact Factor & More
eISSN: 1791-7549pISSN: 0258-851X
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
In Vivo Key Metrics
CiteScore 
3.1
Impact Factor
< 5
SJR
Q4Pharmacology
SNIP
0.84
Topics Covered on In Vivo
Cancer
Overall survival
Amino acid
Lung cancer
Sarcopenia
Lymph node
Neurofibromatosis
Chemoradiotherapy
Genotype
Hepatocellular carcinoma
Cerebral cortex
Breast cancer
Irradiation
Partial response
Thrombotic microangiopathy
Lung
Surgery
Reactive oxygen species
Adjuvant
Osteoid osteoma
In Vivo Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | INT INST ANTICANCER RESEARCH |
| Language | English |
| Frequency | Bi-monthly |
| General Details |
View less
Planning to publish in In Vivo ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in In Vivo
Accurate and Safe Tumor Targeting of Orally-administered Salmonella typhimurium A1-R Leads to Regression of an Aggressive Fibrosarcoma in Nude Mice.
- 29 Oct 2024
- In vivo (Athens, Greece)
Histopathological Correlation Between High Endothelial Venule Neogenesis and the Tumor Microenvironment in Lung Adenocarcinoma.
- 29 Oct 2024
- In vivo (Athens, Greece)
Molecular Hydrogen Therapy in Aneurysmal SAH With RA and Newly-diagnosed SLE, Complicated With Acute Ischemic Infarction: A Case Report of Improved Immune Markers Including Tr1 Cells, Breg Cells and TIM3 Expression on Tc Cells.
- 29 Oct 2024
- In vivo (Athens, Greece)
The Effects of Nebivolol-Gefitinib-Loratadine Against Lung Cancer Cell Lines.
- 29 Oct 2024
- In vivo (Athens, Greece)
Potential Medicinal Efficacy of Alkaline Extract of Pine Seed Shell: Anti-UVC Activity and Macrophage Activation.
- 29 Oct 2024
- In vivo (Athens, Greece)
Microsatellite Instability, Epstein-Barr Virus, p53, and β-Catenin in Early Gastric Cancers: Clinicopathologic Association.
- 29 Oct 2024
- In vivo (Athens, Greece)
Accurate and Safe Tumor Targeting of Orally-administered Salmonella typhimurium A1-R Leads to Regression of an Aggressive Fibrosarcoma in Nude Mice.
- 29 Oct 2024
- In vivo (Athens, Greece)
Histopathological Correlation Between High Endothelial Venule Neogenesis and the Tumor Microenvironment in Lung Adenocarcinoma.
- 29 Oct 2024
- In vivo (Athens, Greece)
Molecular Hydrogen Therapy in Aneurysmal SAH With RA and Newly-diagnosed SLE, Complicated With Acute Ischemic Infarction: A Case Report of Improved Immune Markers Including Tr1 Cells, Breg Cells and TIM3 Expression on Tc Cells.
- 29 Oct 2024
- In vivo (Athens, Greece)
The Effects of Nebivolol-Gefitinib-Loratadine Against Lung Cancer Cell Lines.
- 29 Oct 2024
- In vivo (Athens, Greece)
Potential Medicinal Efficacy of Alkaline Extract of Pine Seed Shell: Anti-UVC Activity and Macrophage Activation.
- 29 Oct 2024
- In vivo (Athens, Greece)
Microsatellite Instability, Epstein-Barr Virus, p53, and β-Catenin in Early Gastric Cancers: Clinicopathologic Association.
- 29 Oct 2024
- In vivo (Athens, Greece)
Compare Similar Journals with In Vivo
Select Journals to Compare with In Vivo
Total journals - 10
You can select up to 3 Journals at a time
Frontiers in Oncology
Publisher: FRONTIERS MEDIA SA
Journal of Clinical Oncology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Medicine
Publisher: Elsevier
Cancers
Publisher: MDPI
Annals of Oncology
Publisher: ELSEVIER
BMC Cancer
Publisher: BMC
Scientific Reports
Publisher: NATURE PORTFOLIO
PLoS ONE
Publisher: PUBLIC LIBRARY SCIENCE
Oncotarget
Publisher: Impact Journals
Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
0 Journals Selected to compare with
In Vivo
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on In Vivo
How long has In Vivo been actively publishing? 
In Vivo has been in operation since 1987 till date.
What is the publishing frequency of In Vivo?
In Vivo published with a Bi-monthly frequency.
How many articles did In Vivo publish last year?
In 2023, In Vivo publsihed 421 articles.
What is the eISSN & pISSN for In Vivo?
For In Vivo, eISSN is 1791-7549 and pISSN is 0258-851X.
What is Citescore for In Vivo?
Citescore for In Vivo is 3.1.
What is SNIP score for In Vivo?
SNIP score for In Vivo is 0.84.
What is the SJR for In Vivo?
SJR for In Vivo is Q4.
Who is the publisher of In Vivo?
INT INST ANTICANCER RESEARCH is the publisher of In Vivo.
